Snowbird Resort Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

Translational Systems Immunology (A9)

Scientific Organizers: Sally John, Soumya Raychaudhuri, Michael Vincent and Mark M. Davis


January 28—February 1, 2018

Snowbird Resort, Snowbird, Utah, USA


Sponsored by AbbVie Inc., AstraZeneca, Biogen, Bioverativ Therapeutics, Merck & Co., Inc. and Theravance Biopharma


Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.
BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Scholarship Deadline: Oct 2, 2017 [details]
Discounted Abstract Deadline: Oct 2, 2017 [details]
Abstract Deadline: Oct 31, 2017 [details]
Discounted Registration Deadline: Dec 1, 2017 [details]

Click here to view Cancellation Policy

Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2018-A9 "Translational Systems Immunology" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On October 2, 2017 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After October 2, 2017 until December 17, 2017 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
October 2, 2017 n/a
Discounted NON-STUDENT Registration
More details
Before and On December 1, 2017 820.00 USD
(includes 200.00 discount)
Regular NON-STUDENT Registration
More details
After December 1, 2017 1020.00 USD
Discounted STUDENT Registration
More details
Before and On December 1, 2017 595.00 USD
(includes 200.00 discount)
Regular STUDENT Registration
More details
After December 1, 2017 795.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.




Discounted Abstract Deadline: October 2, 2017

*All deadlines end at 11:59 PM US Mountain Standard Time

Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is October 31, 2017)

Global Health Travel Award Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: October 2, 2017

*All deadlines end at 11:59 PM US Mountain Standard Time


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: October 31, 2017

*All deadlines end at 11:59 PM US Mountain Standard Time


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:

  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is October 2, 2017)

Discounted Registration Deadline: December 1, 2017

*All deadlines end at 11:59 PM US Mountain Standard Time


Registration Fee: 820.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 595.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1020.00 USD*
Student Registration Fee: 795.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that a few meeting participants have received calls and emails from a number of different housing services - "Exhibitors Housing Services", "Global Housing", etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling and seek to take your lodging reservation and obtain your credit card number. We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report to Keystone Symposia any calls or correspondence you might have received and book only through the lodging link on our website, an established travel agency, or directly with the hotel.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Sunday, January 28 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, February 1 with a closing plenary session from 17:00 to 19:15, followed by a social hour and entertainment. We recommend return travel on Friday, February 2 in order to fully experience the meeting.

SUNDAY, JANUARY 28

16:00—20:00
Arrival and Registration

Ballroom Lobby
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Ballroom Lobby

MONDAY, JANUARY 29

07:00—08:00
Breakfast

Golden Cliff/Eagles
08:00—09:00
Welcome and Keynote Address
Registered attendees can view abstracts starting on 12/28/2017

Ballroom 1-2
* Sally John, Biogen, USA

Sarah Teichmann, Wellcome Trust Sanger Institute, UK
Immunogenomics One Cell at a Time

09:00—11:30
Human Phenotypic Validation via Rare Genetic Mutations
Registered attendees can view abstracts starting on 12/28/2017
Unbiased exome sequencing in Mendelian phenotypes followed by functional annotation of variants are providing unique and direct insights into the function of human immune genes.

Ballroom 1-2
* Sally John, Biogen, USA

Danish Saleheen, University of Pennsylvania, USA
Human Knockout Program

Coffee Break

Helen C. Su, NIAID, National Institutes of Health, USA
Elucidating Molecular Mechanisms of a Novel Inherited Immunodeficiency-Immunodysregulation Disorder

Hakon Hakonarson, Children's Hospital of Philadelphia, USA
Exome Sequencing to Diagnosis and Treat Pediatric Immune Disease

Cecilia Dominguez Conde, CeMM/LBI-RUD, Austria
Short Talk: Insights into DOCK2 Deficiency through the Analysis of Protein Interactions

Michael P. O'Connell, NIAID, National Institutes of Health, USA
Short Talk: EXTL1- and NDST2-mediated Regulation of Allergic Disease

11:30—17:00
On Own for Lunch

11:30—13:00
Poster Setup

Ballroom 3
13:00—22:00
Poster Viewing

Ballroom 3
14:30—16:30
Workshop 1: Translation from Mice to Man: Friendly Debate
How can we optimize our ability to translate observations between rodent and human immunology? Advances in human immune-profiling, and genetics now provides us with greater insight into the human immune system. In addition, several failures of therapeutic approaches in humans that had compelling pre-clinical evidence suggests we may have an opportunity to better understand the relationship between the mice and man immunology. The aim of this workshop will be to compare and contrast our knowledge of rodent and human immunology with a view to applying research methods to achieve optimally translatability between species. Selected short talks will highlight research approaches and the moderators will facilitate discussion that focuses us on an end goal of testing novel immunomodulatory mechanisms in humans.

Ballroom 1-2
* Michael Vincent, Pfizer Inc., USA

* Mark M. Davis, Stanford University, USA

Jeffrey Barrett, Wellcome Trust Sanger Institute, UK
Using Human Genetics for Target Discovery in Inflammatory Bowel Disease

Richard M. Siegel, NIAMS, National Institutes of Health, USA
A Systems Approach to Defining Contributions of TNF-Family Cytokines to Autoimmune Disease Susceptibility Reveals a Protective Role for TL1A/TNFSF15 in IBD

Adam Laing, King's College London, UK
Immune Parameters Are Constrained within a Multidimensional Shape that Describes Immune Competence

16:30—17:00
Coffee Available

Ballroom Lobby
17:00—19:00
Genetics and Epigenetics Variation in Human Immune Traits
Registered attendees can view abstracts starting on 12/28/2017
Understanding natural genetic variability as a foundation for investigation for the immune system networks and pathways.

Ballroom 1-2
* Sarah Teichmann, Wellcome Trust Sanger Institute, UK

Julian C. Knight, University of Oxford, UK
Genetic and Epigenetic Modulators of Monocyte Activation in Health and Disease

Anjana Rao, La Jolla Institute for Allergy and Immunology, USA
Transcriptional and Epigenetic Regulation in Cancer and Cancer Immunotherapy

Nicole Soranzo, Wellcome Trust Sanger Institute, UK
Human Genetic Variation of Hematological Parameters

Dafni Glinos, Wellcome Trust Sanger Institute, UK
Short Talk: Genetic Effects on Transcriptional Variation of Human T Regulatory Cells

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Ballroom 3
19:30—22:00
Poster Session 1

Ballroom 3

TUESDAY, JANUARY 30

07:00—08:00
Breakfast

Golden Cliff/Eagles
08:00—11:15
Advancing our Understanding of Immune Cell Repertoires
Registered attendees can view abstracts starting on 12/28/2017
Progress in understanding the natural variation in immune receptor repertoires and explore potential diagnostic and therapeutic applications.

Ballroom 1-2
* Michael Vincent, Pfizer Inc., USA

Aleksandra Walczak, École Normale Supérieure, France
Diversity of Immune Receptor Repertoires

Mark M. Davis, Stanford University, USA
T-Cell Repertoires and How to Read Them

Coffee Break

Harlan Robins, Fred Hutchinson Cancer Research Center, USA
Reading the Cellular Adaptive Immune System to Diagnose Disease

George Georgiou, University of Texas at Austin, USA
The Human Serological and BCR Antibody Repertoires in Cancer, Autoimmunity or following Vaccination

Nathaniel D. Chu, Massachusetts Institute of Technology, USA
Short Talk: Longitudinal Immunosequencing in Healthy Individuals Reveals Persistent T Cell Receptors Rich in Public Receptors

Scott Nicholas Furlan, Seattle Children's Research Institute, USA
Short Talk: Dissecting the Mechanics of T Cell Alloproliferation

11:15—17:00
On Own for Lunch

13:00—22:00
Poster Viewing

Ballroom 3
16:30—17:00
Coffee Available

Ballroom Lobby
17:00—19:00
Integrative Analysis, Dynamic Networks and Systems Immunology
Registered attendees can view abstracts starting on 12/28/2017
In this session we focus on different methodological approaches to build networks and models of systems.

Ballroom 1-2
* Soumya Raychaudhuri, Brigham and Women's Hospital, Harvard Medical School, USA

Kasper Lage, Massachusetts General Hospital, USA
Human Gene and Protein Networks Perturbed by Genetics to Identify Therapeutics

Manolis Kellis, Massachusetts Institute of Technology, Broad Institute, USA
Talk Title to be Announced

Shai S. Shen-Orr, Technion, Israel
Connect the Dots – An Integrative Cell-Centered View of Immunity

Jiyang Yu, St. Jude Children's Research Hospital, USA
Short Talk: NetBID, a Novel Systems Biology Approach, Identifies Hippo Signaling as a “Hidden” Driver Selectively Programming CD8α+ Dendritic Cell Activity

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Ballroom 3
19:30—22:00
Poster Session 2

Ballroom 3

WEDNESDAY, JANUARY 31

07:00—08:00
Breakfast

Golden Cliff/Eagles
08:00—11:15
Systems Immunology at the Tissue Level
Registered attendees can view abstracts starting on 12/28/2017

Ballroom 1-2
* Nicole Soranzo, Wellcome Trust Sanger Institute, UK

Betty Diamond, Feinstein Institute for Medical Research, USA
Deconstructing Lupus Nephritis through a Single Analysis of Immune Cells in the Kidney

Soumya Raychaudhuri, Brigham and Women's Hospital, Harvard Medical School, USA
Single Cell Sequencing in Rheumatoid Synovial Tissue

Coffee Break

Carolyn B. Coyne, University of Pittsburgh, USA
Immunology of the Human Placenta

Elham Azizi, Memorial Sloan Kettering Cancer Center, USA
Computational Approaches to Understanding Cellular Heterogeneity in the Tumor-Immune Microenvironment

Zoltan Maliga, Harvard Medical School, USA
Short Talk: Deep Immunophenotyping of Idiopathic and ICI-Induced Skin Disease with Cyclic Immunofluorescence Microscopy

Michelle Miron, Columbia University, USA
Short Talk: Human Lymph Nodes Maintain Resident Memory T Cells with High Proliferative Capacity and Clonal Diversity

11:15—17:00
On Own for Lunch

13:00—22:00
Poster Viewing

Ballroom 3
16:30—17:00
Coffee Available

Ballroom Lobby
17:00—19:00
Human Immune Response to Infectious Disease
Registered attendees can view abstracts starting on 12/28/2017

Ballroom 1-2
* Mark M. Davis, Stanford University, USA

Bali Pulendran, Stanford University School of Medicine, USA
Microbiome and B Cell Responses

Purvesh Khatri, Stanford University, USA
Adventures of a "Data Parasite": Translational Medicine using Heterogeneous Public Data

Máté Manczinger, MTA Szegedi Biológiai Kutatóközpont, Hungary
Short Talk: Pathogen Diversity Drives the Evolution of Promiscuous Peptide Binding of Human MHC-II Alleles

Susanna S. Ng, QIMR Berghofer Medical Research Institute, Australia
Short Talk: Identifying Novel Immune Checkpoint Molecules that can be Targeted to Improve CD4+ T Helper Cell Function during Chronic Infection

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Ballroom 3
19:30—22:00
Poster Session 3

Ballroom 3

THURSDAY, FEBRUARY 1

07:00—08:00
Breakfast

Golden Cliff/Eagles
08:00—11:30
Immuno-Oncology from Basic Science to Clinical Practice
Registered attendees can view abstracts starting on 12/28/2017
The next generation of oncology drugs relies upon a deeper knowledge of the interaction between host immune system and tumour biology.

Ballroom 1-2
* Kasper Lage, Massachusetts General Hospital, USA

Shannon J. Turley, Genentech, Inc., USA
Leukocyte Function and Positioning in Diverse Stromal Niches

Alexandra Snyder, Memorial Sloan Kettering Cancer Center, USA
T Cell Receptor Sequencing (TCR) in Immuno-Oncology: Systemic, Intratumoral and Antigen-Specific Immunity

Coffee Break

Cassian Yee, University of Texas MD Anderson Cancer Center, USA
Terminators: No Fate but What You Make

Wendy Broom, Genocea Biosciences, USA
Neoantigen Identification using ATLAS Across Multiple Tumor Types Highlights Limitations of Prediction Algorithms

Pauline L. Gonnord, INSERM UMR1043, France
Short Talk: High-Dimensional Immunophenotyping of Chronic Lymphocytic Leukemia (CLL) Patients Reveals Remodeling of the CD8+ T Cell Compartment by Tumor Progression and Predicts Need for Therapy

Daniel Wells, Parker Institute for Cancer Immunotherapy, USA
Short Talk: Genetic Mechanisms of Immune Evasion in Colorectal Cancer

Mazlina Ismail, University College London, UK
Short Talk: Characterising the T Cell Receptor Repertoire of Patients with Non-small-cell Lung Cancer (NSCLC) within the Lung TRACERx Study

11:30—17:00
On Own for Lunch

14:30—16:30
Workshop 2: CyTOF Change to Human Immunoprofiling

Ballroom 1-2
* Soumya Raychaudhuri, Brigham and Women's Hospital, Harvard Medical School, USA

Petter Brodin, Karolinska Institutet, Sweden
Convergence of Immune Systems in Diverse Newborn Children during the First Months of Life

Jean-Louis Palgen, CEA, France
Prime and Boost Vaccination Elicit a Distinct Innate Myeloid Cell Immune Response

Luis Miguel Franco, National Institutes of Health, USA
Immune Regulation by Glucocorticoids Can Be Linked to Cell-Lineage-Specific Transcriptional Responses

Oisin Huhn, University of Cambridge, UK
Characterizing the Architecture of the Decidual Natural Killer Cell Niche using Time of Flight Mass Cytometry

Ainhoa Perez-Diez, NIAID, National Institutes of Health, USA
Antibody Profiling Identifies a Strong and Widespread Auto-Immune Response in Idiopathic CD4 Lymphopenic Patients

Arnon Arazi, Broad Institute, USA
Beyond Clustering: Using scRNA-seq Data to Generate Quantitative, Testable Models of Human Disease

Ning Jiang, University of Texas at Austin, USA
High-Throughput Detection of T Cell Antigen Reactivity at Single T Cell Level using de novo Generated DNA-Linked MHC Tetramers

16:30—17:00
Coffee Available

Ballroom Lobby
17:00—19:00
Clinical Immunoprofiling and Patient Stratification
Registered attendees can view abstracts starting on 12/28/2017

Ballroom 1-2
Holden T. Maecker, Stanford School of Medicine, USA
Comprehensive Immune Profiling and Functional Analysis of Human Aging / Response to Therapy

Michael Vincent, Pfizer Inc., USA
Systems Approaches to Compare the Effects of Selective Immunokinase Inhibitors in Humans

Sally John, Biogen, USA
A Network Approach to Understanding the Role of the Immune System in Neurodegenerative Disease

Sathya Baarathi Shanthi Ravichandran, Indian Institute of Science, India
Short Talk: Identification of a Robust Blood-Based Biomarker Signature for Chronic Systemic Inflammation through a Meta-Analysis of Disease Networks

19:00—19:15
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 12/28/2017

Ballroom 1-2
19:15—20:15
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Ballroom 2-3
20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Ballroom 2-3

FRIDAY, FEBRUARY 2

 
Departure


*Session Chair †Invited, not yet responded.



We gratefully acknowledge support for this conference from:


Directors' Fund


These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.



Keystone Symposia thanks our Sponsors for generously supporting this meeting:

AbbVie Inc. AstraZeneca
Biogen Bioverativ Therapeutics
Merck & Co., Inc. Theravance Biopharma

We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health

Grant No. 1 R13 AI136444-01

Funding for this conference was made possible (in part) by 1 R13 AI136444-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



Pfizer Research Technology Center


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676